PRPO
Precipio Inc (PRPO)
Healthcare • NASDAQ • $22.07+3.25%
- Symbol
- PRPO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $22.07
- Daily Change
- +3.25%
- Market Cap
- $38.27M
- Trailing P/E
- N/A
- Forward P/E
- 54.81
- 52W High
- $33.63
- 52W Low
- $18.00
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- 1.30
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Company websiteResearch PRPO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.